Position in ABBV
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$5,997,084
+$911,733 QoQ
Shares Held
23,832
+1.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#46
of 285 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 89.47633434038268.ToString("F0")%
Shared 0.ToString("F0")%
None 10.52366565961732.ToString("F0")%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hennion & Walsh Asset Management, Inc. holds $55,949,166 across 10 Drug Manufacturers - General names. ABBV ranks #4 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,360 | $17,223,816 | |
| 2 | JNJ |
Johnson & Johnson
|
43,755 | $11,112,457 | |
| 3 | MRK |
Merck & Co., Inc.
|
72,515 | $9,318,177 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
23,832 | $5,997,084 | |
| 5 | GRFS |
Grifols SA
|
592,173 | $4,192,584 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
28,507 | $3,601,574 | |
| 7 | AMGN |
Amgen Inc
|
7,665 | $2,775,649 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
18,045 | $1,039,752 |
All Filings in ABBV
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,997,084 | 23,832 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $5,085,351 | 23,382 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $5,941,882 | 26,005 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $6,343,501 | 27,397 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $4,957,724 | 26,709 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $5,922,711 | 28,268 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $5,829,626 | 32,806 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $6,487,415 | 32,851 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $4,830,517 | 28,163 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $5,178,195 | 28,436 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $5,003,051 | 32,284 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $5,535,044 | 37,133 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $5,843,105 | 43,369 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $6,349,619 | 39,842 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $6,428,845 | 39,780 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $4,513,348 | 33,629 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,148,167 | 33,613 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $4,298,184 | 26,514 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $3,703,460 | 27,352 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,127,690 | 28,995 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,237,048 | 28,738 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,923,887 | 27,018 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||